Skip to main content
. Author manuscript; available in PMC: 2011 Apr 1.
Published in final edited form as: Am J Cardiol. 2010 Apr 1;105(7):917–921. doi: 10.1016/j.amjcard.2009.11.025

Table 1.

Clinical characteristics by tertiles of C-reactive protein (mg/L) levels

Variable Tertile 1
<2.7 mg/L
N=172
Tertile 2
2.7 to 10 mg/L
N=169
Tertile 3
> 10 mg/L
N=173
P value*
Age, mean ± sd (years) 65 ±14 65 ±15 71 ±17 <0.001
Women 62 (36%) 65 (38%) 86 (50%) 0.023
Body mass index, mean ± sd
(kg/m2)
28± 5 30 ± 7 28± 7 0.539
Hypertension 108 (63%) 107 (63%) 129 (75%) 0.029
Hyperlipidemia 112 (65%) 103 (61%) 107 (62%) 0.702
Current smoker 35 (20%) 47 (28%) 31 (18%) 0.584
Diabetes mellitus 20 (12%) 44 (26%) 54 (31%) <0.001
Killip class 2, 3 or 4 31 (18%) 42 (25%) 67 (39%) <0.001
Infection within 2 weeks prior 7 (4%) 18 (11%) 77 (45%) <0.001
Comorbidity index <0.001
0 88 (51%) 42(35%) 26 (15%)
1-2 57 (33%) 65 (38%) 62 (36%)
≥ 3 27 (16%) 44 (26%) 85 (49%)
Electrocardiogram
Inferior location 64 (38%) 60 (37%) 59 (36%) 0.629
Presence of Q waves 88 (56%) 85 (57%) 90 (59%) 0.579
ST elevation myocardial
infarction
49 (29%) 45 (28%) 32 (19%) 0.039
Biomarkers
Time from symptoms to C-
reactive protein measurements,
median (25th- 75th percentile)
6.3 (3.1-10.5) 6.9 (2.8- 12.2) 4.0 (0.7- 10.7) 0.091
Peak troponin, median (25th-
75th percentile)
1.08(0.31-3.57) 0.94 (0.30, 3.93) 0.52 (0.18, 1.520) 0.001
Peak creatine kinase-MB,
median (25th- 75th percentile)
42 (11-135) 31 (11-113) 14 (7-30) <0.001